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Abstract.  Entactin (nidogen), a  150-kD  sulfated gly- 
coprotein,  is a major component of basement mem- 
branes and forms a highly stable noncovalent complex 
with laminin. The complete amino acid sequence of 
mouse entactin has been derived from sequencing of 
cDNA clones.  The 5.9-kb cDNA contains a  3,735-bp 
open reading frame followed by a  3'-untranslated re- 
gion of 2.2 kb.  The open reading frame encodes a 
1,245-residue polypeptide with an unglycosylated Mr 
of 136,500,  a  28-residue  signal peptide,  two Asn- 
linked glycosylation sites, and two potential Ca  2÷- 
binding sites.  Analysis of the deduced amino acid se- 
quence predicts that the molecule consists of two 
globular domains of 70 and 36 kD separated by a 
cysteine-rich domain of 28 kD.  The COOH-terminal 
globular domain shows homology to the EGF precur- 
sor and the low density lipoprotein receptor.  Entactin 
contains six EGF-type cysteine-rich repeat units and 
one copy of a  cysteine-repeat motif found in thyro- 
globulin. The Arg-Gly-Asp cell recognition sequence 
is present in one of the EGF-type repeats, and a  syn- 
thetic peptide from the putative cell-binding site of en- 
tactin was found to promote the attachment of mouse 
mammary tumor cells. 
B 
ASEMENT membranes are a type of extracellular matrix 
that form thin sheets separating epithelial, endothelial, 
muscle, fat, and nerve cells from connective tissue 
(51). Epithelial cells require contact with a basement mem- 
brane to maintain their morphology and differentiated phe- 
notype, and this is a result of interactions between basement 
membrane molecules and cell surface receptors  for them 
(26).  The major components of basement membranes are 
type IV collagen, laminin, entactin, and heparan sulfate pro- 
teoglycan (reviewed in reference 48).  Entactin is a  150-kD 
sulfated glycoprotein first identified as a product of a terato- 
carcinoma-derived parietal endoderm line (6). It is identical 
to nidogen, a polypeptide originally isolated as an 80-kD 
proteolytic fragment from the Engelbreth-Holm-Swarm tu- 
mor (49). Immunostaining has shown entactin to be a ubiqui- 
tous component of adult,  fetal, and extraembryonic base- 
ment membranes (4,  6,  17,  29,  37, 48,  54),  and it is also 
synthesized by early embryos (17, 54), embryonal carcinoma 
cells (7, 11,  17), and mesenchyme cells (28, 29,  52). 
Laminin and entactin can be coextracted from cell culture 
media and basement membranes in the form of a highly sta- 
ble noncovalent complex (7,  17,  32, 40).  As visualized by 
electron microscopy, the complex consists of one entactin 
molecule bound to one of the short arms of laminin, near the 
center of the cross (40).  Entactin also binds to fibronectin 
and type IV collagen, but has no affinity for heparan sulfate 
proteoglycan (18). Progress in elucidating the function ofen- 
tactin has been slow, due to its susceptibility to proteolysis 
during extraction and the fact that denaturants required to in- 
hibit proteases and dissociate the laminin-entactin complex 
cause a loss of  binding activity (18, 40). We have used cDNA 
cloning to obtain the complete amino acid sequence of mouse 
entactin, and this has provided new insights into the struc- 
ture, function, and evolution of the molecule. The entactin 
sequence has been found to contain EGF-like cysteine-rich 
repeats, segments showing homology to the EGF precursor, 
the low density lipoprotein (LDL)  ~  receptor, and thyroglob- 
ulin, and possible sites for Ca  2+- and cell binding. 
Materials and Methods 
Purification and NHz-terrainal  Amino Acid 
Sequencing of  Entactin 
The extracellular matrix proteins synthesized by the mouse parietal endo- 
derm cell line M1536-B3  were extracted as previously described (10), and 
resolved by SDS-PAGE (35)  on 5% polyacrylamide slab gels. The bands 
were visualized by soaking the gels in 1 M KCI (24). The entactin bands 
were cut out and the protein isolated by electroelution (30). The preparation 
was  homogeneous when  tested by  SDS-PAGE.  Samples  were dialyzed 
against three 2.000-vol  changes of H20  over a  36-h  period,  and  NH2- 
terminal sequence analysis of purified entactin was performed on an amino 
acid sequencer (model 890M; Beckman Instruments, Inc., Palo Alto, CA). 
1.  Abbreviation used in this paper:  LDL, low density lipoprotein. 
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Two M1536-B3 eDNA libraries in Lgtll, one primed with oligo(dT) and one 
primed with a laminin B2 chain-specific  oligonucleotide,  were construct- 
ed and screened as described (14).  ~611 (Fig.  1)  was  isolated  from the 
oligo(dT)-primed  library by screening  with the 32p-labeled insert of ~.IE, 
a rat entactin cDNA clone isolated previously  (15). A 950-bp Eco RI/Pvu 
It fragment from the 5' end of the ),611 insert and a 700-bp Eco RI/Pvu II 
fragment from the 3' end of the insert were then used to screen both libraries. 
Due to the high concentration of the laminin B2 primer used in constructing 
the specifically  primed library, many entactin clones were obtained due to 
semirandom annealing of the primer. 
Sequencing of cDNAs 
Restriction  fragments of the k611 insert were subcloned  into bacteriophage 
MI3 mpl8 or mpl9 and sequenced by the dideoxy chain termination method 
(46)  using [¢t-35S]dATP and the Klenow  fragment. The other eDNA in- 
serts were  subcloned into the Bluescript KS plasmid (Stratagene  Cloning 
Systems, La Jolla, CA) and partially sequenced  by the supereoiled  plasmid 
dideoxy technique (9). The k611 insert and the 2.2-kb 3' Eco RI fragment 
of the L107 insert were subcloned into Bluescript and sequenced in their en- 
tirety by constructing nested deletions using exonuclease Ill and S1 nuclease 
(27, 36). Both strands were completely  sequenced,  using specific synthetic 
oligonucleotide  primers where necessary m fill in gaps. Secondary structure 
analysis of the derived amino acid sequence was performed by the method 
of Gamier et al. (20) using MacGene Plus software (Applied Genetic Tech- 
nology, Inc., Fair  view Park, OH). A search of the Protein Identification Re- 
source and GenBank databases was accomplished using Bionet software (In- 
telligenetics,  Inc., Palo Alto,  CA). 
Northern Blot Analysis of  Entactin RNA 
Methods for extraction of total RNA, formaldehyde-agarose  gel electropho- 
resis, blotting to Gene Screen,  hybridization of blots to 32P-labeled probes, 
and subsequent washing steps have been described (16). The hybridization 
probe was the 240-bp internal  Eco RI fragment of ~.104, labeled with 32p 
by nick translation. The blot was exposed to x-ray film at -70°C overnight 
with an intensifying  screen. 
Cell Attachment Assay 
The synthetic peptide SIGFRGDGQTC  was prepared  by Dr. Ming F. Tam, 
Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan. The pep- 
tide was conjugated to BSA-coated 35-mm plastic petri dishes as described 
by Pytela et al. (43). The peptide-coated plates were blocked with 3% BSA in 
PBS overnight at 4°C before plating the cells. Mouse mammary tumor cells 
(MMT 060562, American Type Culture Collection, Rockville,  MD) were 
labeled for 12 h with 2.5 IICi/ml [3H]thymidine in DME +  10% fetal calf 
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Figure  1.  Map  of mouse  entactin cDNA  clones.  The  thick  line 
represents the coding region and the thin line represents the 3' un- 
translated region. Restriction sites for Sac I (S), Pst I (P), Bam HI 
(B), Eco RV (R), Eco RI (E), and Hind III (H) are indicated. ),611 
and L663 were obtained from the oligo (dT)-primed library; the 3' 
ends were lost due to cleavage at the natural Eco RI sites during 
construction of the library.  ZI10, M16, ~,104,  and ~107 were iso- 
lated from the laminin B2 oligonucleotide-primed library. L203 was 
isolated from the oligo (dT)-primed library by screening with a re- 
striction fragment from the 3' end of Z,107. All cDNAs were charac- 
terized by restriction endonuclease mapping and partial sequenc- 
ing. The L611 insert and the 3'-most Eco RI fragment of LI07 were 
:ompletely sequenced. 
serum. The cells were harvested by trypsinization, and 0.5-1.0  ×  105 cells 
per dish were plated  in serum-free DME on dishes coated  with peptide- 
BSA conjugate or BSA alone. The plates were incubated at 37°C for 4 h in an 
atmosphere of 100% humidity/5 % CO2 in air, then washed twice with 1 ml 
PBS and once with 0.5 ml 0.05% trypsin l~ remove unattached  cells.  The 
cells were removed by incubating with 1 ml trypsin, transferred to scintilla- 
tion vials,  mixed  with scintillation fluid,  and counted  in a  scintillation 
counter.  Percent attachment was calculated  as follows: 
[cpm  in peptide-coated  plate  -  cpm in BSA-coated plate] 
×  100 
total cpm per plate. 
Results 
Isolation  of  Mouse Entactin cDNA Clones 
Previously we had characterized a rat entactin eDNA clone, 
~IE, obtained by screening a kgtl 1 library with anti-entactin 
antiserum (15).  To isolate mouse entactin cDNA clones, an 
oligo(dT)-primed M1536-B3  library  was  probed  with  the 
nick-translated ~,IE insert, yielding a phage carrying a 3.4-kb 
insert, ~611. The oligo(dT)-primed library and a specifically 
primed library were then screened with nick-translated re- 
striction fragments from the 5' and 3' ends of the L611 insert, 
and a series of  clones covering a total of  5,959 bp was isolated 
(Fig. 1). The size of entactin mRNA was estimated to be 6-kb 
by Northern blot analysis (Fig. 2), indicating that the eDNA 
is nearly full length. Entactin mRNA is considerably more 
abundant in basement membrane-secreting M1536-B3 cells 
(Fig. 2, lane 2) than in F9 embryonal carcinoma cells (lane 
1 ),  which produce much less of the protein. 
Features of the Entactin cDNA and Protein Sequence 
The entactin eDNA sequence and the deduced amino acid se- 
quence are shown in Fig. 3. The cDNA contains a 3,735-bp 
open reading frame beginning at the ATG codon at nucleo- 
tide 12, which lies in a favorable context for translation initi- 
ation (33) and terminating at a TGA stop codon at nucleotide 
3,747. The 5' untranslated region is very short (11 bp), and 
it is likely that we are missing most of the 5' leader. After 
the open reading frame is a 2.2-kb 3' untranslated region, an 
ATTAAA polyadenylation signal, and a poly(A) tail. While 
Figure 2.  Northern blot analysis of en- 
tactin gene expression. Aliquots of to- 
tal RNA (5  I.tg per lane) from mouse 
F9 embryonal carcinoma cells (lane 1 ) 
and M1536-B3 ceils grown in suspen- 
sion culture for 6 d (lane 2) were sepa- 
rated on a 0.75% agarose/2.2 M  form- 
aldehyde gel, blotted onto Gene Screen, 
and  hybridized  to  the  nick-translated 
240-bp  internal  Eco  RI  fragment  of 
LI04.  The positions of the  18  S  and 
28 S  rRNAs  in the gel are indicated. 
The size of entactin mRNA (6 kb) was 
estimated  by  comparison  to  Hind  III 
fragments  of  bacteriophage  L  DNA 
(not shown). 
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Figure 3. Nucleotide sequence of the composite entactin cDNA and the derived amino acid sequence. Numbering of the amino acid sequence 
begins at the NH2 terminus of mature entactin, as determined by direct protein sequencing. An arrow indicates the signal peptide cleavage 
site. The two potential N-linked glycosylation sites are underlined and cysteine residues are marked with stars.  The ATTAAA sequence 
that may serve as the polyadenylation signal is underlined with a double line, and the RGD tripeptide is boxed. 
Durkin et al. Amino Acid Sequence of Entactin  2751 the sequence ATTAAA was found to be much less efficient 
than the canonical AATAAA motif in promoting cleavage 
and polyadenylation in one set of experiments, it occurs up- 
stream of the poly(A) addition site in 12% of mRNAs (53). 
The open reading frame encodes a 1,245-amino acid poly- 
peptide with an unglycosylated 34, of 136,500;  this is close 
to the Mr of 143,000  estimated for the  in vitro translation 
product of entactin mRNA (15).  The NH2 terminus of ma- 
ture entactin  was determined to be LNXQELFPFGPG by 
Edman degradation,  and  this  agrees  with the  sequence of 
residues 1-12. The sequence of the first 28 residues (-28 to 
-1) is characteristic of a signal peptide (50), which predicts 
that the mature entactin polypeptide has an unglycosylated 
Mr of 133,500  and  consists of 1,217 amino acids.  The se- 
quences of residues  1-10, 204-212,298-307,  351-360,  and 
621-630,  with the exception of two amino acids, match the 
NH2-terminal sequences of intact nidogen and its  130-,  100-, 
80-,  and  40-kD  proteolytic  fragments,  respectively  (41), 
confirming that entactin and nidogen are identical proteins. 
Secondary structure analysis of the deduced entactin amino 
acid sequence predicts that the polypeptide has no extended 
a-helical structure and consists primarily of D-sheet,  D-turn, 
and random coil structures, consistent with circular dichro- 
ism measurements (41). 
Entactin possesses both N- and O-linked oligosaccharides 
(29,  49), and two potential sites for N-linked glycosylation 
(N-X-S or T) are found in the entactin sequence.  Sites for 
the addition of N-acetylgalactosamine to serine or threonine 
residues do not appear to have a simple consensus sequence, 
and it is believed that O-glycosylation occurs on clustered 
serine and threonine  residues in exposed, proline-rich  re- 
gions of the polypeptide (25).  A number of sites that meet 
these criteria are present in entactin (for example, residues 
57-72,  138-142,281-288,  547-556, and 965-984).  Another 
posttranslational modification of entactin is tyrosine O-sulfa- 
tion (42). Tyrosines at residues 262 and 267 appear to be the 
most likely sulfate acceptor sites since they are surrounded 
by acidic residues,  a common feature of tyrosine sulfation 
sites (31). 
When the sequence of the 1,326-bp rat LIE insert was com- 
pared with that of the mouse cDNA,  it was found that the 
overlap began at nucleotide 282 in the mouse sequence and 
diverged after nucleotide 1,250. The final 354 nucleotides of 
the rat clone apparently represent either an intron or a clon- 
ing artifact, and the first 972 nucleotides are derived from 
near the NH2 terminus of entactin, not the COOH terminus 
as reported originally (15).  The overlapping mouse and rat 
sequences  are  94%  identical  at  the  nucleotide  level  (not 
shown) and 93 % identical at the amino acid level (Fig. 4). 
Possible Cell- and CaZ+-binding Properties of Entactin 
Inspection of the entactin sequence revealed the presence of 
the tripeptide RGD  (residues  672-674),  located in a  cys- 
teine-rich domain of the molecule (see below). The RGD se- 
quence is the cell recognition site of a number of adhesive 
proteins (45),  which led us to investigate whether this se- 
quence in entactin possessed cell-binding activity. Cell attach- 
ment assays were performed using the synthetic undecapep- 
tide SIGFRGDGQI'C, corresponding to residues 668-678. 
When  coupled  to  BSA-coated  petri  dishes  the  peptide 
promoted the attachment of MMT cells in a dose-dependent 
manner, and 90-100 % attachment was obtained at concen- 
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Figure 4. Comparison of rat and mouse entactin sequences.  The 
deduced amino acid sequence of nucleotides  1-972 of the rat ME 
cDNA (15) are compared with the sequence of residues 63-385  of 
mouse entactin. Dashes indicate residues that are identical in both 
species, and an asterisk marks an extra amino acid present in rat 
entactin. The rat sequence includes changes found after publication 
of the original sequence. 
trations >5 ~tg per plate (Fig. 5). The entactin sequence also 
contains  two potential  Ca2+-binding  sites,  DLELEAGDD- 
VVS  (residues  15-26)  and  DVNLDLDDDGAD (residues 
250-261). The first, third, fifth, ninth, and twelfth positions 
have oxygen-containing residues  that  can coordinate  with 
Ca  2+ (34). Binding of 4sCa2+ to nitrocellulose-blotted entac- 
tin has been observed (unpublished observations). Second- 
ary  structure  analysis predicts  that  the  Ca2+-binding  sites 
are not  in the  EF-hand conformation typical of the  Ca  2+- 
binding sites of intracellular Ca2+-binding  proteins (34), but 
nonEF-hand  Ca2+-binding  sites  are  found  in  extracellular 
proteins such as thrombospondin (36). 
Cysteine-rich  Repeats in Entactin 
Mature entactin contains 48 cysteine residues located mainly 
in three clusters, and most of the cysteines are organized into 
an EGF-like repeat pattern of ~40 residues,  with six cys- 
teines in conserved positions in each repeat (Fig. 6 A). The 
sequence of 12 other positions in the repeat unit is also con- 
served, and a consensus sequence can be derived.  The six 
cysteines  in  each  repeat  probably  form  three  disulfide- 
bonded loops, as in EGF (8). Single copies of the EGF-type 
repeat occur between residues 358-395  and at the COOH 
terminus, and four copies, one of which contains the RGD 
tripeptide, occur in tandem between residues 640-816.  Im- 
mediately after there  is a  stretch of 75  residues  (817-891) 
containing  six cysteines that do  not  conform to  the  EGF 
pattern.  A  computer  search  of the  GenBank and  Protein 
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Figure 5. Attachment of MMT cells to a synthetic peptide contain- 
ing the RGD sequence of entactin. MMT cells were plated on petri 
dishes coated with 0.2-20 I.tg of the synthetic peptide  SIGFRG- 
DGQTC (residues 668-678),  and percent attachment was measured 
as described in Materials and Methods. Each point is the average 
of duplicate dishes. The data shown are from a representative ex- 
periment.  Greater than  100% attachment is sometimes observed, 
due to experimental variability. 
Identification Resource databases revealed that this segment 
is similar to a cysteine-rich repeat motif found in thyroglobu- 
lin, the precursor of thyroid hormone (Fig. 6 B).  Residues 
844-891  of entactin are 51% identical to residues 29-75 of 
bovine thyroglobulin (38). 
Homology to the LDL Receptor and the EGF Precursor 
In  addition  to  containing  cysteine-rich  repeats  similar  to 
those found in EGE a region near the COOH terminus ofen- 
tactin shows homology to a cysteine-poor segment of  both the 
EGF precursor  (23)  and  the  LDL  receptor  (55).  Over a 
stretch of 192  amino acids (residues 953-1,144)  entactin is 
31% identical to residues 523-714 of the mouse EGF precur- 
sor and 32 % identical to residues 411-608 of the human LDL 
receptor (Fig. 7). There are also sequence similarities in the 
EGF-type repeat units after this segment in all three proteins 
(not shown).  Besides the  sequence homologies in this re- 
gion, the three polypeptides display some similarities in the 
organization of their EGF-type repeats (Fig.  8). 
Model for the Structure of  Entactin 
Electron microscopy shows that entactin has an asymmetric 
dumbbell shape, consisting of two globules of 38 and 85 kD, 
separated by a 17-nm stalk ofT/kD (40). On the basis of this 
and analysis of the amino acid sequence, one can predict the 
existence of at least three domains in entactin, diagramed in 
Fig. 9. The estimated positions of the major proteolytic frag- 
ments in the intact molecular are also indicated.  Domain I 
(residues 1-639, 70 kD) probably corresponds to the larger 
globular domain,  and it contains one of the EGF-type re- 
peats, the Ca2+-binding  sites, and the tyrosine sulfation site. 
Upon further structural and functional analysis, this domain 
may be divided into several subdomains. The sequence sur- 
rounding the NH2 terminus of the 100-kD proteolytic frag- 
ment is rich in prolines and charged residues, and this seg- 
ment may be more exposed and accessible to proteases. The 
cysteine-rich domain II (residues 640-889, 28 kD) contains 
four EGF-like repeats, one thyroglobulin-like repeat, and the 
putative cell-binding  site,  and  it forms a  disulfide-bonded 
stalk connecting the globular domains. The smaller globule, 
domain III (residues 890-1,217,  36 kD) has the EGF precur- 
sor/LDL receptor-homologous region,  and one EGF-type 
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Figure 6. Cysteine-rich repeats in entactin. (A) EGF-type repeats. The sequences of the six EGF-type repeats were aligned by inspection, 
and the six cysteine residues in each repeat are boxed. Below is a consensus sequence that includes residues found in the same position 
in at least three of the repeats. The sequence of one of the EGF-like repeats in the mouse EGF precursor  (23) is shown for comparison. 
(B) Thyroglobulin-like repeat. Residues 817-891 of entactin were aligned with residues 13-79 of bovine thyroglobulin (TG) (38). Residues 
that are identical in both proteins are boxed. 
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Figure  7. Homology of entac- 
tin to the EGF precursor and 
the  LDL  receptor.  Residues 
953-1,144  of  entactin  were 
aligned with residues 523-714 
of the mouse EGF precursor 
(23) and residues 411-608 of 
the human LDL receptor (55) 
by inspection, after the align- 
ment  of  the  latter  two  se- 
quences  by Yamamoto et al. 
(55), by introducing only one 
additional gap. Identical resi- 
dues are boxed. This segment 
appears to contain four copies 
of a repeat unit with the con- 
sensus sequence I Y W T D 
XI2GX2RX 10PXGIX2 
D Xs. 
repeat. The disulfide-bonded regions appear to confer pro- 
tease resistance,  as the  NH2 termini of the 80 and 40 kD 
fragments occur just before two of the cysteine-repeat units. 
Discussion 
The complete primary structure of mouse entactin has been 
determined from cDNA sequencing,  and many of the fea- 
tures predicted from the deduced amino acid sequence are 
consistent with data obtained from other experimental ap- 
proaches.  The results presented in this report suggest new 
properties for entactin, such as cell- and Ca2÷-binding,  and 
reveal the multidomain organization of the molecule.  The 
availability of the entactin sequence should stimulate further 
investigations  on  its  contribution  to  basement  membrane 
function and assembly. 
Entactin  appears to be a  mosaic protein  that  may have 
evolved by  "exon-shuffling"  and  acquired  segments  from 
other genes. The cysteine-rich EGF-type repeats found in en- 
tactin occur in a wide variety of extracellular proteins such 
as growth factors, receptors, developmental gene products, 
extracellular matrix proteins,  and proteins of the coagula- 
tion, fibrinolytic, and complement systems (5,  13, 44).  The 
B1  and B2 chains of laminin possess cysteine-rich repeats 
that  show  some similarity to EGF,  but they contain  eight 
cysteines per repeat instead of the usual  six (14,  47).  The 
EGF-like units are believed to be involved in receptor-ligand 
--100  residues  Homologous 
Region 
Entactin  NH2--Vl  I  I  I  I  t'-.'~l  i  i I"1COOH 
I 
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Figure 8.  Organization  of the cysteine-rich  repeats in entactin,  the 
EGF precursor,  and the LDL receptor.  Open boxes represent  the 
EGF-type repeats.  The hatched box represents  the thyroglobulin- 
type repeat found in entactin. The diamonds represent the ligand- 
binding cysteine-rich repeats in the LDL receptor; these have a mo- 
tif that is also found in complement component C9 (13). 
interactions;  both EGF  and  the  EGF-like domain of uro- 
kinase-type plasminogen activator bind to cell surface recep- 
tors (2, 8). One of the EGF-type repeats in entactin may be 
involved in cell-binding and the functions of the other five 
remain to be determined. Entactin also contains one copy of 
a cysteine-repeat motif that occurs 10 times in each 330-kD 
thyroglobulin monomer (38); the significance of this is not 
known. 
The COOH-terminal globular domain of entactin shows 
homology to a region found in both the LDL receptor and 
the EGF precursor, indicating that these three functionally 
dissimilar proteins share a common ancestral precursor. In 
vitro mutagenesis was used to delete this domain in the LDL 
receptor, along with the three flanking EGF-like repeats, and 
the mutant receptor was unable to bind LDL, to recycle after 
binding 13-very  low density lipoprotein (I~-VLDL), and to re- 
lease I3-VLDL at acid pH (12).  Since the ligand-binding site 
of the  LDL receptor is  located  in  the  NH~ terminus  (see 
Fig.  8),  one function of this domain in entactin may be to 
modulate the binding  properties of other  segments of the 
molecule. 
I  II  III 
im  it  I 
NH2 
'  200  ' 
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100kD 
80kD 
Ill  121 31415V///J  161 COOH 
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40kD 
Figure 9. Structural domains in entactin. The numbered boxes rep- 
resent the six EGF-like repeats (Fig. 6) and the hatched box rep- 
resents the thyroglobulin-like  repeat.  Domains I and III probably 
comprise the  large  and small globules,  respectively,  seen  in the 
electron microscope (40) and domain II forms the stalk connecting 
them. The positions of the 130-, 100-, 80-, and 40-kD proteolytic 
fragments  of nidogen are  shown.  The precise NH2  termini are 
known from protein sequencing (41); the COOH termini were esti- 
mated from the sizes of the fragments as determined by SDS-PAGE. 
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is suggested by the discovery of the RGD sequence in one 
of the EGF-type repeats, and we have demonstrated that a 
synthetic peptide derived from the RGD site of entactin has 
cell-binding activity. Although it is possible that cells may 
attach to the peptide via receptors for other RGD-containing 
proteins such as fibronectin and vitronectin, we have found 
that entactin itself promotes cell adhesion, and attachment to 
entactin is inhibited by RGD-containing peptides (Chakra- 
varti, S., and A. E. Chung, manuscript in preparation). In 
another study, anti-entactin antiserum partially inhibited the 
attachment of epidermal cells to the M1536-B3  matrix (1). 
Laminin has two distinct cell-binding sites apparently recog- 
nized by different receptors, one located in a proteolytic frag- 
ment consisting of the intersection of the three short arms of 
the cross (fragment 1), and another located in a fragment de- 
rived from the long arm (fragment 8) (3, 21). The fragment 
1 cell-binding site has been mapped to a sequence located in 
one of the cysteine-rich repeats in the B1 chain (22).  Binding 
of entactin to laminin may provide a third ceil-binding site 
in the complex, or it may mask the fragment 1 site; cells pos- 
sessing only fragment 1-specific receptors did not attach to 
the laminin-entactin complex (3). Adhesion of cells to RGD- 
containing proteins is mediated by a class of heterodimeric 
cell-surface receptors known as integrins (45), and an entac- 
tin-specific receptor might possibly be a member of the inte- 
grin family. 
The laminin-entactin complex has been reported to bind 
16 Ca  2+ ions (39), and our results indicate that at least two 
of the Ca2+-binding sites may be present in entactin. In ad- 
dition to the calmodulin-type Ca2÷-binding loops identified 
in the entactin sequence, other possible sites for Ca2+-bind  - 
ing are the EGF-type repeats.  Several  of the blood coag- 
ulation proteins  have  EGF-like domains containing I~-hy- 
droxylated aspartate or asparagine residues that have been 
correlated with Ca2÷-binding (44). The third and fifth EGF- 
type repeats in entactin fall into the type C group of EGF-like 
sequences described by Rees et al.  (44),  as they contain 
asparagine residues (residues 699 and 789, respectively) lo- 
cated  in  a  postulated consensus  site  for 13-hydroxylation. 
Ca  2÷ promotes the self-aggregation of laminin (39, 56), and 
the  laminin-entactin complex can be  efficiently extracted 
from basement membranes using EDTA-containing buffers 
(40).  Another  Ca2+-binding  protein,  SPARC/osteonectin/ 
BM-40, is a component of basement membranes (19). These 
observations suggest that the assembly and stabilization of 
basement membranes  involve Ca2÷-dependent  interactions 
between the various protein constituents. 
Knowledge of the entactin sequence will facilitate attempts 
to map the sites on the molecule involved in binding to other 
extracellular matrix components.  By electron microscopy 
the laminin-binding site of entactin was localized to one of 
the globular domains, but it was not possible to determine 
which one (40).  The 100-kD  fragment of entactin, but not 
the 80-kD, was found to possess binding activity for laminin, 
fibronectin, and type IV collagen (18). Fig. 9 shows that the 
100-kD fragment loses mass at both ends to generate the 80- 
kD fragment, so the binding site cannot be determined more 
accurately. By analogy with the LDL receptor, however, the 
ligand binding activity of entactin may be  located in the 
NH2-terminal  domain. During the purification of entactin, 
exposure to denaturants causes a loss of affinity for laminin 
(18, 40), and studies on the interaction of entactin with lami- 
nin and other matrix molecules will require entactin in its na- 
tive conformation. 
Although laminin and entactin are present as an equimolar 
complex in basement membranes (17), their synthesis is not 
coordinately regulated (11, 15,  17, 54).  Moreover, the level 
of entactin protein does not always correlate with the level 
of its mRNA; during the retinoic acid induced differentiation 
of F9 cells the amount of entactin increases modestly (7, 11, 
17) while entactin mRNA levels increase to a much greater 
extent (15). Isolation of a nearly full-length entactin eDNA 
is the first step in analyzing the structure of its gene and iden- 
tifying the transcriptional regulatory elements. The contri- 
bution of posttranscriptional, translational, and posttransla- 
tional mechanisms to the control of entactin gene expression 
will also need to be explored. 
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